CORCEPT THERAPEUTICS INC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CORCEPT THERAPEUTICS INC (CORT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$34.29 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$34.29M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$27.45M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$11.65M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$14.95M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$73.46M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$194.00K.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$17.00K.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$174.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$34.29M 10-Q · filed 2018-05-09 | -$61.74M derived: sum of 2 quarters · filed 2018-05-09 | -$73.39M derived: sum of 3 quarters · filed 2018-05-09 | -$88.34M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | -$27.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$39.09M derived: sum of 2 quarters · filed 2018-02-28 | -$54.04M derived: sum of 3 quarters · filed 2018-02-28 | -$73.46M 10-K · filed 2018-02-28 |
| 2017-09-30 | -$11.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$26.59M derived: sum of 2 quarters · filed 2017-11-03 | -$46.01M 10-Q · filed 2017-11-03 | -$46.08M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | -$14.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$34.36M 10-Q · filed 2017-08-02 | -$34.44M derived: sum of 3 quarters · filed 2018-05-09 | -$34.53M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | -$19.41M 10-Q · filed 2018-05-09 | -$19.49M derived: sum of 2 quarters · filed 2018-05-09 | -$19.58M derived: sum of 3 quarters · filed 2018-05-09 | -$19.59M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$165.00K derived: sum of 2 quarters · filed 2018-02-28 | -$172.00K derived: sum of 3 quarters · filed 2018-02-28 | -$194.00K 10-K · filed 2018-02-28 |
| 2016-09-30 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$97.00K derived: sum of 2 quarters · filed 2017-11-03 | -$119.00K 10-Q · filed 2017-11-03 | -$102.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$29.00K 10-Q · filed 2017-08-02 | -$12.00K derived: sum of 3 quarters · filed 2018-02-28 | -$12.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$22.00K 10-Q · filed 2017-05-02 | -$5.00K derived: sum of 2 quarters · filed 2018-02-28 | -$5.00K derived: sum of 3 quarters · filed 2018-02-28 | -$5.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $17.00K derived: sum of 2 quarters · filed 2018-02-28 | $17.00K derived: sum of 3 quarters · filed 2018-02-28 | -$17.00K 10-K · filed 2018-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | -$34.00K 10-Q · filed 2016-11-02 | -$34.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$34.00K 10-Q · filed 2016-08-03 | -$34.00K derived: sum of 3 quarters · filed 2017-03-06 | -$50.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | -$34.00K 10-Q · filed 2016-05-04 | -$34.00K derived: sum of 2 quarters · filed 2017-03-06 | -$50.00K derived: sum of 3 quarters · filed 2017-03-06 | -$98.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$16.00K derived: sum of 2 quarters · filed 2017-03-06 | -$64.00K derived: sum of 3 quarters · filed 2017-03-06 | -$174.00K 10-K · filed 2017-03-06 |
| 2014-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$64.00K derived: sum of 2 quarters · filed 2015-11-06 | -$174.00K 10-Q · filed 2015-11-06 | -$214.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | -$48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$158.00K 10-Q · filed 2015-08-07 | -$198.00K derived: sum of 3 quarters · filed 2016-03-10 | -$263.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | -$110.00K 10-Q · filed 2015-05-08 | -$150.00K derived: sum of 2 quarters · filed 2016-03-10 | -$215.00K derived: sum of 3 quarters · filed 2016-03-10 | -$219.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$105.00K derived: sum of 2 quarters · filed 2016-03-10 | -$109.00K derived: sum of 3 quarters · filed 2016-03-10 | -$127.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$69.00K derived: sum of 2 quarters · filed 2014-11-07 | -$87.00K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$22.00K 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | -$18.00K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | -$151.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |